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Abstract The effect of ultraviolet B (UVB) irradiation on endo- 
thelin-1 (ET-1) and ET receptor expression was examined using 
cultured normal human keratinocytes. Keratinocytes secreted 
ET-1 in the medium at a level of 2.1 pgldayllO s cells. UVB 
irradiation up to 10 mJIcm z increased ET-1 secretion 3-fold, and 
potentiated expression of mRNA for ET-1. Both ET A and ET R 
receptor mRNAs were detected in keratinocytes, and their ex- 
pression was up-regulated by 5 mJ/cm 2 UVB irradiation. 
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1. Introduction 
The endothelins (ET) are a family of highly conserved 21- 
amino acid peptides originally isolated from vascular endothe- 
lial cells on the basis of their potent vasoconstrictor activity [1 ]. 
ET consists of three isopeptides, termed ET-1, ET-2 and ET-3 
(ETs), while their eceptors are classified, both pharmacologi- 
cally and molecularly, into ET A and ETB subtypes [2-5]. The 
ET A receptor has different affinities for the three ET isoforms 
in the order of ET-I>ET-2>>ET-3. The ETB receptor binds 
ET-1, -2 and -3 with similar affinity. Intensive studies have 
increased the knowledge on processing, pharmacological ef- 
fects, receptors, signal transduction and antagonists of ETs [for 
review see 611].  As a mitogen, ET-1 has been reported to 
stimulate DNA synthesis in Swiss 3T3 fibroblasts [12-14], Rat- 
1 fibroblasts [15], rat mesangial cells [16] and glial cells [17]. 
Recently, ET-1 secreted from keratinocytes has been shown 
to act as a paracrine growth factor for melanocytes [18-20], 
while we demonstrated that ET-1 also works as an autocrine 
growth factor for keratinocytes [21]. In our aforementioned 
study, keratinocytes treated with tumor necrosis factor-c~ 
(TNF-c0 or interleukin- 1 ~ (IL- 1 ~) was found to have increased 
levels of secreted ET-1. Since TNF-c~ and IL-lc~ are known to 
be two major cytokines released by ultraviolet B (UVB) irradi- 
ation [22], we speculated that ET-1 is involved as a mediator 
during UVB-induced inflammation. In this study, we examined 
the effect of UVB irradiation on the ET-1 and ET receptor 
expression of cultured keratinocytes. 
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2. Materials and methods 
2.1. Cell culture and UVB irradiation 
Normal human keratinocytes from infant foreskins were cultured in 
serum-free medium [23,24]. Keratinocytes were grown in keratinocyte 
growth medium (KGM, Kurabo Co., Osaka, Japan). KGM contained 
epidermal growth factor (10 ng/ml), insulin (5 ,ug/ml), hydrocortisone 
(0.5/.tg/ml), ethanolamine (0.1 raM), phosphoethanolamine (0.1mM), 
CaC12 (0.15 mM), and brain pituitary extract (0.4%, v/v), in modified 
MCDB 153 medium. All experiments were carried out using third- or 
fourth-passage k ratinocytes grown in KGM. After KGM was re- 
placed with phosphate-buffered saline (PBS), the cells were exposed to 
UVB (FL20SE30 lamps, Toshiba, Japan), followed by incubation with 
keratinocyte basal medium (KBM, Kurabo Co.) which contained only 
ethanolamine and phosphoethanolamine in modified MCDB 153 me- 
dium. 
2.2. Radioimmunoassay (RIA ) 
ET-l-like immunoreactivity n the conditioned medium was deter- 
mined using an ET-1, -2 (high sensitivity) ~2'I assay system (RPA 545, 
Amersham International, Buckinghamshire, UK) according to the 
manufacturer's in tructions. Rabbit anti-ET antibody used in this assay 
kit cross-reacts with ET-1, -2 and big ET-1, but not ET-3. Keratinocytes 
in a 35-mm size dish were exposed to UVB and then incubated in KBM. 
After 48 h incubation, the conditioned medium was collected and the 
number of cells in the plate counted after tripan blue staining. ET-l-like 
immunoreactivity was expressed as pg/day/plate. 
2.3. Northern blot analysis 
Keratinocytes, prior to subconfluency, in 100-mm size dishes were 
exposed to 5 mJ/cm 2 UVB and further cultured in KBM for 12 h. Total 
RNA was extracted by the guanidinium thiocyanate/phenol/chloro- 
form method [25]. Ten/zg of total RNA was separated by formalde- 
hyde/1.1% agarose gel electrophoresis and transferred to a Hybond-N 
membrane (Amersham). The cDNA for human ET B receptor [26] was 
labeled to a specific activity of 8 × 108 c.p.m.//tg with [c~-32p]dCTP by 
the random priming method, and used as a probe. Hybridization and 
washing were performed as described [26], followed by autoradio- 
graphy at -80°C for 5 days. 
2.4. Reverse transcription-polymerase chain reaction (RT-PCR) 
RT-PCR was performed using GeneAmp RNA PCR Kit (Perkin- 
Elmer Co., Norwalk, CT) according to the manufacturer's in tructions. 
cDNA was generated using 1/lg of total RNA as a template in the 
presence of cloned murine Moloney leukemia virus reverse transcrip- 
tase and random hexamers. ET-1 primers were designed as 5'-TGC 
TCC TGC TCT TCC CTG ATG GAT AAA GAG TGT GTC-3" 
(sense) and 5'-GGT CAC ATA ACG CTC TCT GGA GGG CTT-3' 
(antisense) [27]. The primers were predicted to amplify a 462 base pair 
DNA fragment (nucleotides 157 to 618) [2]. ET A receptor primers were 
designed as 5'-AGC TTC CTG GTT ACC ACT CAT CAA-3' (sense) 
and 5'-T CAA CAT CTC ACA AGT CAT GAG-3' (antisense) [28]. 
The primers were predicted to amplify a 714 base pair DNA fragment 
(nucleotides 136 to 850) [29]. PCR was performed for various et num- 
ber of cycles (at 94°C for 1 min, 60°C for 1 min, 72°C for 2 min) in 
the presence of AmpliTaq DNA polymerase. Aliquots of each of the 
amplification products were applied to a 6% polyacrylamide gel for 
electrophoresis, and DNA was visualized by ethidium bromide stain- 
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ing. PCR products were subjected to direct sequencing by the dideoxy 
chain termination method [30]. 
3. Results 
3.1. Effect of UVB irradiation on ET-1 secretion 
Fig. 1 shows the ET-l-like immunoreactivity secreted from 
keratinocytes during the48 h incubation period after exposure 
to UVB irradiation. Non-treated keratinocytes secreted ET-1 
at a level of 9.4 pg/day/plate (2.1 pg/day/105 cells), and UVB- 
irradiated keratinocytes increased ET-1 secretion dose-depen- 
dently. An approximate 3-fold increase of ET-1 secretion was 
achieved by 10 mJ/cm 2 UVB, however an excessively high dose 
of UVB irradiation reduced the ET-1 secretion (Fig. 1). Mor- 
phological observations (Fig. 2) and trypan blue staining of the 
cells prior to collection of the media (legend of Fig. 1) con- 
firmed that 10 mJ/cm 2 or a higher dose of UVB irradiation 
damaged the keratinocytes. Accordingly, the remaining experi- 
ments were carried out at 5 mJ/cm 2 UVB. 
3.2. Effect of UVB irradiation on ET-1 and ET receptor mRNA 
expression 
Ten/2g of total RNA, which had been extracted from the 
keratinocytes 12 h after 5 mJ/cm 2 UVB irradiation, was sepa- 
rated by agarose gel electrophoresis (Fig. 3A). The transferred 
RNA was hybridized with a probe for ET B receptor (Fig. 3B). 
When compared with non-treated cells, UVB irradiation signif- 
icantly increased the ETB receptor expression i  keratinocytes. 
Since ET-1 and ETA mRNAs were not detected by Northern 
blot analysis at the condition tested (10/2g of total RNA), 
RT-PCR (Fig. 3C and D) was performed using 1 /2g of total 
RNA as a template from each sample shown in Fig. 3A. The 
PCR products were found to coincide to human ET-1 and ET A 
receptor, respectively, by direct sequencing [2,29]. Fig. 3C 
clearly indicates that UVB irradiation increased the ET-1 
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Fig. 1. Effect of UVB irradiation on ET-1 secretion of keratinocytes. 
The ET-l-like immunoreactivity secreted from keratinocytes during the 
48 h incubation period after exposure to UVB irradiation was measured 
by a radioimmunoassay. ET-l-like immunoreactivity was expressed by 
pg/day/plate. The experiment was repeated four times with similar 
results being achieved each time. n = 3, mean + S.D. Cell numbers in 
each plate were 4.5 × 105 cells (0 mJ/cm2), 4.3 × 105 cells (2.5 mJ/cm2), 
3.6 × 105 cells (5 mJ/cm2), 0.9 x 105 cells (10 mJ/cm2), 0.2 / 105 cells (20 
mJ/em2), 0.03 × 105 cells (40 mJ/cm2). 
G 
G 
Fig. 2. Morphological observation of the UVB-irradiated cells. (A) 
0 mJ/cm 2, (B) 5 mJ/cm 2, (C) 10 mJ/cm 2, (D) 20 mJ/cm 2. Bar: 
100 ,um. 
mRNA expression. Meanwhile, Fig. 3D demonstrates that 
ETA mRNA is expressed in non-treated keratinocytes (slightly 
positive at 25 cycles), and that UVB irradiation enhances the 
mRNA expression. 
4. Discussion 
Ultraviolet absorption by skin leads to molecular and cellular 
damage with consequent impairment of tissue function. Ker- 
atinocytes comprise th majority of epidermal cells and protect 
skin from ultraviolet damage with the assistance ofmelanocytes 
and Langerhans cells. Cutaneous inflammation caused by UVB 
irradiation is mediated by various cytokines, among which 
TNF-~ and IL-lct have been thought to be the two major 
cytokines [22]. The stimulatory effect of TNF-c~ and IL-lc~ on 
ET-1 expression has been shown in cells of epithelial origin 
[19,21,31,32]. In this study, we clearly demonstrated that UVB 
irradiation increases mRNA and secreted protein levels for 
ET- 1 in keratinocytes. This result suggests that a portion of the 
effect induced by UVB irradiation is exerted through ker- 
atinocyte-secreted IL-lc~ and TNF-~. At a low dose of UVB 
irradiation (5 mJ/cm2), an increased amount of ET-1 may con- 
tribute to the re-growth of melanocytes [18-20] and ker- 
atinocytes [21]. However, at a high dose of UVB irradiation, 
ET- 1 secretion from keratinocytes was found to be reduced and 
keratinocytes destroyed. 
We were able to detect mRNAs for ET A and ETB receptors 
in keratinocytes for the first time. This result is compatible with 
our previous data showing that iodinated ET-1 competed with 
unlabeled ET-1 and -2 with similar affinities, but with a lower 
affinity with unlabeled ET-3 [21]. UVB irradiation up-regulated 
the expression of both ET A and ETB receptors in keratinocytes. 
The increase in receptor expression as well as in ET-1 expres- 
sion confirms that ET-1 is involved as a mediator during the 
inflammation process caused by UVB irradiation. These find- 
ings are supported by in vivo data that immunoreactive ET-1 
and ET-l-binding sites in mice skin are increased by UVB 
irradiation (manuscript in preparation). 
ETs have short-term actions such as vasoconstriction a d 
long-term actions such as cell growth-stimulatory activity [6- 
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Fig. 3. The effect of UVB irradiation on ET-1 and ET receptor mRNA 
expression in keratinocytes. Total RNA was extracted from the ker- 
atinocytes 12 h after 5 mJ/cm 2 UVB irradiation. (A) ethidium bromide 
staining of the gel (10,ug of total RNA in each lane), (B) Northern blot 
analysis for ETB receptor from the gel shown in A, (C) RT-PCR for 
ET-1 (1/tg of total RNA as a template from each sample shown in A), 
(D) RT-PCR for ET A receptor (1 fig of total RNA as a template from 
each sample shown in A). The numbers under the bands represent PCR 
cycles. 1, 0 mJ/cm 2 UVB; 2, 5 mJ/cm 2 UVB. 
11]. Since keratinocytes expressed ETA receptor, we expected 
a short-term action of ET-1. In preliminary experiments, we 
observed that ET-1 stimulated the contraction of collagen gel 
embedded with fibroblasts and/or keratinocytes. However, we 
failed to demonstrate such an activity by UVB irradiation in 
this model, thereby suggesting that UVB irradiation has vari- 
ous effects on keratinocytes other than the enhancement of
ET-1 secretion. We therefore speculate that UVB-induced ET-1 
from keratinocytes may work as a paracrine factor for mela- 
nocyte growth and melanization [19], and as an autocrine 
growth factor for keratinocytes [21]. 
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